Range of diagnostic spinal fluid tests needed to differentiate concurrent brai... ( NEW ORLEANS Teasing out the exact t...)

Range of diagnostic spinal fluid tests needed to differentiate concurrent brain diseases

Date:4/20/2012

NEW ORLEANS Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.

In a series of studies being presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans, Penn researchers demonstrated that, while tests created for AD are effectively diagnosing the condition when it's clear cut, additional tests are needed to address the many cases with mixed pathology.

"With the emergence of disease-modifying treatments for AD and other neurodegenerative diseases, it will be of utmost importance to accurately identify the underlying neuropathology in patients," said senior author John Q. Trojanowski, MD, PhD, professor of Pathology and Laboratory Medicine and co-director of the Center for Neurodegenerative Disease Research at Penn.

In one study, the Penn team compared results of a test looking at levels of tau and amyloid beta (Aβ) in the spinal fluid, using two different types of analytical platforms. They determined that values from the two platforms could effectively be transformed into equivalent units, and these values accurately distinguished AD from FTLD. A cutoff of 0.34 for the t-tau:Aβ1-42 ratio had 90 - 100 percent sensitivity and 91-96.7 percent specificity to differentiate FTLD cases, respectively.

In another study, the team looked at patient cases with more than one underlying neurodegenerative disease and compared the accuracy of the biomarkers using clinical and neuropathological diagnosis. They determined that cerebral spinal fluid (CSF) Aβ and tau assays provided a valid diagnos
'/>"/>

Contact: Kim Menard
kim.menard@uphs.upenn.edu
215-200-2312
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Bluestar Silicones Launches a New Range of Silbione(R) TCS 7560 & 7561 Elastomers for Lingerie, Support Stockings and Medical Textile Applications
2. Orange Healthcare Joins the mHealth Alliance to Develop Mobile Health Solutions in West Africa
3. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
4. Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range
5. Rev. Michel Faulkner Seeks to Retire Charlie Rangel from New York's 15th Congressional Seat
6. New Heart Health Booster Supports Blood Pressure in the Normal Range*
7. Good Bye, Snake Oil! Grab your Orange Juice and Daily Virus Viper™ to Safeguard Against Micro-nutrient Deficiencies
8. Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus
9. Strange Artifact Identified as Ancient Anti-Snoring Device
10. HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces
11. Dynowatt Offers Facebook Fans a Chance to See the Rangers and Astros Play for Texas Bragging Rights

Post Your Comments:

(Date:5/20/2013)... 20, 2013 Dr. Robert Mokbel is ... trained to use the Laser Assisted New Attachment Procedure, ... patients with gum disease. LANAP may help many Fountain ... gum disease restore the jawbone support necessary to support ... of plaque and tartar in the mouth. Daily oral ...

(Date:5/20/2013)... May 20, 2013 In order to prepare ... and wellness team from DrSmartphoneMD launched an article series to ... , The series launched with the precautions that ... of the DrSmartphoneMD program are not one of the 3.5 ... that more than 90% of all skin cancer cases are ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 Daily Gossip, online ... provide its readers with useful tips that can help them ... , According to the website Natural Vitiligo Treatment System ... the numerous positive reviews it has received from the persons ... until now, but Daily Gossip has interviewed some of the ...

(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...

(Date:5/20/2013)... May 20, 2013 Mombo from ... national conference of the US Lactation Consultant Association (USLCA) ... including nurses, doctors and other health professionals. , ... at helping lactation professionals discover and learn about the ... of the most popular nursing pillows, which new mothers ...

Breaking Medicine News(10 mins):Health News:Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants 2 Health News:Combat Skin Cancer In Summer Months 2 Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2 Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2 Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2

[0] Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants [0] Combat Skin Cancer In Summer Months [0] New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine [0] Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com [0] Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference

... and ... IVUS, SAN DIEGO, Nov. 8 Volcano Corporation,(Nasdaq: ... measurement (FM) products designed to enhance the diagnosis and,treatment of ... quarter and first nine months of fiscal 2007. For ...

... Nabi ... Biologics to Biotest, BOCA RATON, Fla., ... third quarter,financial results. The company recorded a net loss of $15.9 ... which included,$7.5 million, or $0.12 per share, of expenses for unusual ...

... to Aid ... Decision-Making, MILFORD, Mass., ... Synapt(TM) HDMS,System to hasten its drug discovery efforts in the area ... C, HIV, osteoporosis, osteoarthritis, and high blood pressure.,Installed in June, the ...

... Hispanic youth report better dental health habits than their non-Hispanic ... researchers at Columbia University Mailman School of Public Health. ... the Journal of Health Care for the Poor and Underserved, ... community in America. , The study, a snapshot of more ...

... stomach-shielding drugs, patient health has suffered, researchers say , , ... Vioxx and Bextra off the market to spare patients, ... new study suggests. , Rates of gastrointestinal events serious ... cox-2 inhibitor medications were ordered off the market in ...

... have identified a way to detect neural progenitor cells ... system cells, in the living human brain using a ... The finding, supported by the National Institutes of Health ... depression, Parkinson,s disease, brain tumors, and a host of ...

Volcano Reports Record Third Quarter Revenues Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting Medivir Reshapes Drug Discovery Study of minority New York City youth finds unequal burden of poor dental health Vioxx Ban Tied to Rise in Serious GI Trouble Imaging neural progenitor cells in the living human brain

(Date:5/20/2013)... SAN DIEGO , May 20, 2013 Volcano ... and manufacturer of precision guided therapy tools designed to ... vascular disease, today announced it will highlight its efforts ... including its Fractional Flow Reserve (FFR) and iFR ® ... clinical and educational presentations and events at EuroPCR 2013 ...

(Date:5/20/2013)... Pa. , May 20, 2013 B. ... patient, clinician and environmental safety with products, services ... B.Braun will feature its innovative Outlook® 400ES and ... and barcoding capabilities at the American Association of ... at the Boston Convention ...

(Date:5/20/2013)... May 20, 2013 Landauer, Inc. (NYSE: ... environmental radiation measurement and monitoring, outsourced medical physics services ... its Board of Directors declared, at its meeting on ... $0.55 per share for the third quarter of fiscal ... 2013, to shareholders of record on June 7, 2013. ...

Breaking Medicine Technology:Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4 B. Braun Committed To Improving Patient Safety 2 Landauer, Inc. Declares Regular Cash Dividend 2

[0] Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 [0] B. Braun Committed To Improving Patient Safety [0] Landauer, Inc. Declares Regular Cash Dividend

... Conn., Sept. 16 MedClean Technologies (OTC Bulletin Board: ... technology for the treatment and disposal of medical waste ... today announced it has signed a distribution agreement with ... organization with over 125 years of combined experience in ...

... Quarterly Dividend -- ABBOTT PARK, Ill., Sept. 16 ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...

Cached Medicine Technology:MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 2 MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 3 Abbott Declares 347th Consecutive Quarterly Dividend 2 Abbott Declares 347th Consecutive Quarterly Dividend 3 Abbott Declares 347th Consecutive Quarterly Dividend 4 Abbott Declares 347th Consecutive Quarterly Dividend 5 Abbott Declares 347th Consecutive Quarterly Dividend 6

MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems Abbott Declares 347th Consecutive Quarterly Dividend

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Adenosine Deaminase, Body Fluid ADAMTS13 Activity & Inhibitor (VWF Cleaving Protease)Acylcarnitine Quantitative Profile, Plasma Acycloguanosine, Urine